BIOPTRON AG, Switzerland

Part of the Zepter Group, BIOPTRON AG produces medical devices of the highest Swiss quality & guarantees excellence in production standards.
In 1996 BIOPTRON AG merged with Zepter International, a Swiss-based multinational company that produces, sells and distributes top quality consumer goods in the following fields: Medical, Cosmetics, Luxury, Home Art, and Home Care.
BIOPTRON AG belongs to Zepter's Medical Division that offers a range of clinically tested and certified medical devices and healthcare products.

The ZEPTER Group

 

  • 7 factories
  • 320,000 m2 business space
  • 5 continents
  • 40 countries
  • Over 130,000 consultants
  • Over 65,000,000 presentation attendees annually
  • Over 80,000,000 satisfied users
  • Over 760,000,000 products sold

BIOPTRON WORLDWIDE

OVER 50 COUNTRIES
OVER 20 YEARS ON THE INTERNATIONAL MARKET
OVER 3,000,000 DEVICES SOLD

Our Mission

BIOPTRON AG is one of the leading manufacturers of light therapy devices in the world today. Our company is dedicated to long-term, in-depth research and development, as well as to the production of unique medical devices – the BIOPTRON Light Therapy System.
Our goal is to consolidate our position as market leader and promote the international acceptance of light therapy through the constant application of innovative solutions and advancements. Since its merger with Zepter International, more than 3 million devices have succeeded in satisfying their users.

LIVE HEALTHY. LIVE LONGER.

Research & Development

Years of experience and research have confirmed the positive effects of BIOPTRON Light Therapy and have led to its use in the treatment of a wide range of medical conditions. The therapy is now recognized worldwide as a new and innovative form of treatment for preventing and healing various medical conditions.
BIOPTRON AG’s researchers are constantly working with experts, researchers and physicians from many countries on the characteristics and therapeutic effectiveness of BIOPTRON light therapy.
BIOPTRON AG counts more than 500 scientists, 1,000 clinics and 5,000 medical practitioners.

Quality Certification

BIOPTRON AG in-house laboratories are constantly engaged in the testing and optimization of BIOPTRON devices in line with the latest scientific studies carried out by independent institutions. Simultaneously, BIOPTRON devices are further certified by accredited, independent testing institutions. Our business processes, including R&D, supplier evaluation, the supply of components to production, ongoing inspections and the production of all devices, comply with the European Community medical directive 93/427EEC as well as with specific local market regulations.

FDA
510 (k) clearance for pain

For further information visit "510(k) Premarket Notification Database" Our 510(k) No: K032216